By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Wyeth (Richmond, VA) 

2248 Darbytown Road

Richmond  Virginia  23261  U.S.A.
Phone: n/a Fax:


At Wyeth, we have a vision of leading the way to a healthier world. We've committed ourselves to achieving this vision by making quality, integrity, and excellence the hallmarks of our business. Through recruitment, development, and motivation of the best people, we are continually growing and improving our business. We lead in innovation by linking pharmaceutical, biotechnology, and vaccine technologies.

The Richmond Wyeth Pharmaceutical and Wyeth Consumer Healthcare Facility consists of three separate sites totaling over 1.73 million square feet on 348 acres. Two sites, one manufacturing/office complex and the Wyeth Consumer Healthcare Global Research Complex, are all located near downtown Richmond. The other site, the Wyeth Pharmaceutical Complex and Distribution Center is located approximately six miles from downtown Richmond near the airport in Henrico County.

Located near downtown Richmond are the manufacturing/office complex and Pharmaceutical R & D. PR&D are the Wyeth Consumer Healthcare facilities. The PR&D group develops new formulations and supports/improves marketed formulations of Wyeth Consumer Healthcare products worldwide.

Our Darbytown complex was constructed in 1980 as a liquid manufacturing/packaging and dry products plant. In 1990, ChapStick manufacturing/packaging was added, followed by Denorex and Preparation H suppositories in 1995. The Richmond production capabilities include the manufacture and packaging of capsules, tablets, gels, creams, suppositories, tube products, and suspensions. In addition, Richmond is noted for the manufacturing and packaging of high-volume liquids. To support other product additions since 1990, numerous renovations have been made. These additions include renovations to the bulk manufacturing areas in 1997, a QA Annex in 2001, and a locker room and cafeteria in 2002.

This facility now consists of an administrative/lab/non-production area, a liquid-focused factory/pharmacy, a solids-focused factory, a topical-focused factory, and warehousing space.

Wyeth Pharmaceuticals is a leading pharmaceutical manufacturing facility in the Richmond tri-city and Tidewater area. Our highly efficient team manufactures such renowned products as Robitussin®, Dimetapp®, Children's Advil® and ChapStick®.

Each member of the Richmond organization is vital to the continuation of our organization's success. Our future achievements will rely on the balanced efforts of more than 1,400 employees.

Lead the way to a better career at Wyeth.

Last Updated: 11-14-03

Key Statistics

Ownership: Public

Web Site: Wyeth (Richmond, VA)
Employees: 42,000 Worldwide
Symbol: WYE

Big Pharma


Company News
Wyeth (WYE) And Progenics Pharmaceuticals, Inc. (PGNX) Initiate Second Global Phase 3 Trial Of Intravenous Methylnaltrexone To Treat Post-operative Ileus 12/20/2006 3:21:14 PM
Wyeth (WYE) Wins Philadelphia Phase II Diet Drug Cases10/19/2005 5:13:15 PM
Wyeth (WYE) Joins Nationwide Program To Assure Patient Access To Important Pharmaceutical Products10/19/2005 5:13:14 PM
Wyeth-Vaccines Researchers Honored By Pharmaceutical Industry10/19/2005 5:13:07 PM
Wyeth (WYE) To Present At The Smith Barney Citigroup Health Care Conference10/19/2005 5:13:06 PM
Wyeth (WYE) Release: National Institutes of Health (NIH) State-Of-The-Science Panel Supports Use Of Hormone Therapy For Treatment Of Moderate To Severe Menopausal Symptoms10/19/2005 5:13:06 PM
Wyeth (WYE) Comments On Earnings Guidance For 2005 First Quarter; Addresses Analyst Estimates10/19/2005 5:13:05 PM
Wyeth-Vaccines Researchers Honored By Pharmaceutical Industry10/19/2005 5:13:05 PM
Wyeth (WYE) Sets Webcast For Annual Meeting Of Stockholders10/19/2005 5:13:02 PM
Wyeth (WYE) Release: InductOs(TM) (rhBMP-2/ACS) Receives Additional European Commission Marketing Authorization10/19/2005 5:13:02 PM